Cruz Looks to
Replace America’s Medical Reliance on China with Israel
By David Sidman April 17, 2020 , 3:44 pm
Breaking Israel News
Latest News Biblical perspective
“I will bless those who bless you Genesis
12:3 (The Israel Bible™)
Israeli Prime Minister Benjamin Netanyahu meets with
Texas senator Ted Cruz at Netanyahu’s office in Jerusalem on December 17, 2012.
(Photo: Amos Ben Gershom/GPO/FLASH90)
Senators Ted Cruz (R-TX) and Chris Coons (D-DE) are
launching a bipartisan effort to ween the U.S off of medical reliance on China
and replace it, at least partially, with Israel. More specifically, the two
senators have launched the initiative to mitigate the coronavirus pandemic in
America. Both members of the Senate Foreign Relations Committee are also
seeking $12 million in order to “enhance partnerships between companies in the
United States and Israel to develop innovative medical projects aimed at
detecting, treating, and curing COVID-19.”
“I’ve long
said that China poses the most significant, long-term geopolitical threat to
the United States. Our dependence on China for life-saving medications and
treatments is deeply problematic,” Cruz said in a tweet. “Israel is not only
our friend and ally, but also a global leader in medicine with which we already
cooperate on exactly those issues. I’m proud to push forward to ensure both
American and Israeli companies can work together to develop cures and
treatments to defeat COVID-19.”
Echoing Cruz’a sentiments, Sen. Coons said: “The United
States and Israel are world leaders in the medical technology industry, and it
is in the interest of all Americans, Israelis, and the rest of the world that
we work together to fight COVID-19. This virus knows no borders, and our bill
underscores the importance of international collaboration in the face of a
truly global pandemic,”.
Israel’s medical industry has been on the front lines of
developing both treatments and even vaccines in the battle against the novel
coronavirus. Israel’s Pluristem Therapeutics Inc.’s treatment boasts
a 100% survival rate in patients who have been reated. Additionally,
researchers at MIGAL, a research institute located in Israel’s Northern
Galilee, say that they’re on the path to developing a coronavirus vaccine.
No comments:
Post a Comment